E Edlmann1,2, D C Holl3, H F Lingsma4, J Bartek5,6,7, A Bartley8, J Duerinck9, T S R Jensen10, J Soleman11, N C Shanbhag12,13, B Indira Devi12,13, T Laeke13,14, A M Rubiano13,15, K Fugleholm10, J van der Veken9, M Tisell8, P J Hutchinson16,13, R Dammers3, A G Kolias16,13,17. 1. Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Box 167, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. eedlmann@nhs.net. 2. University Hospitals Plymouth NHS trust, Derriford Road, Plymouth, PL6 8DH, UK. eedlmann@nhs.net. 3. Department of Neurosurgery, Erasmus Medical Centre, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. 4. Department of Public Health and Medical Decision Making, Erasmus MC Stroke Centre, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. 5. Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden. 6. Department of Clinical Neuroscience and Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 7. Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. 8. Department of Neurosurgery, Sahlgrenska University Hospital, Blå stråket 5, 41345, Gothenburg, Sweden. 9. Department of Neurosurgery, UZ Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium. 10. Department of Neurosurgery, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. 11. Department of Neurosurgery, University Hospital of Basel and University of Basel, Basel, Switzerland. 12. Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bangalore, India. 13. NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, UK. 14. Neurosurgery Unit, Addis Ababa University, School of Health Sciences, Addis Ababa, Ethiopia. 15. INUB/MEDITECH Research Group, El Bosque University, Bogotá, Colombia. 16. Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Box 167, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. 17. Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Abstract
BACKGROUND: Chronic subdural haematoma (CSDH) is a pathology that is frequently encountered by neurosurgeons. Nevertheless, there is a lack of guidelines based on solid evidence. There has been a recent and considerable increase in the interest on management and outcomes for CSDH. Therefore, we systematically reviewed all currently running randomised controlled trials (RCTs) in chronic subdural haematoma to understand the areas under investigation and plan future collaborative trials. METHODS: Clinical trials databases (Cochrane Controlled Register of Trials, WHO ICTRP and clinical trials.gov) were searched for trials relevant to chronic subdural haematoma. It was then established which trials were currently running and fulfilled robust research methodology for a RCT. RESULTS: There are 26 currently running RCTs in CSDH, with the most common topics covering application of steroids (7), surgical techniques (5) and tranexamic acid (5). Further to this, there are trials running on other pharmacological agents (4), middle meningeal artery (MMA) embolisation (2) and peri-operative management (3). CONCLUSIONS: Pharmacological agents are a particular focus of CSDH management currently, and a wealth of studies on steroids will hopefully lead to more harmonised, evidence-based practice regarding this in the near future. Surgical techniques and new procedures such as MMA embolisation are also important focuses for improving patient outcomes. There is an on-going need for future RCTs and evidence-based guidelines in CSDH, particularly including low- and middle-income countries, and it is hoped that the establishment of the iCORIC (International COllaborative Research Initiative on Chronic Subdural Haematoma) will help address this.
BACKGROUND:Chronic subdural haematoma (CSDH) is a pathology that is frequently encountered by neurosurgeons. Nevertheless, there is a lack of guidelines based on solid evidence. There has been a recent and considerable increase in the interest on management and outcomes for CSDH. Therefore, we systematically reviewed all currently running randomised controlled trials (RCTs) in chronic subdural haematoma to understand the areas under investigation and plan future collaborative trials. METHODS: Clinical trials databases (Cochrane Controlled Register of Trials, WHO ICTRP and clinical trials.gov) were searched for trials relevant to chronic subdural haematoma. It was then established which trials were currently running and fulfilled robust research methodology for a RCT. RESULTS: There are 26 currently running RCTs in CSDH, with the most common topics covering application of steroids (7), surgical techniques (5) and tranexamic acid (5). Further to this, there are trials running on other pharmacological agents (4), middle meningeal artery (MMA) embolisation (2) and peri-operative management (3). CONCLUSIONS: Pharmacological agents are a particular focus of CSDH management currently, and a wealth of studies on steroids will hopefully lead to more harmonised, evidence-based practice regarding this in the near future. Surgical techniques and new procedures such as MMA embolisation are also important focuses for improving patient outcomes. There is an on-going need for future RCTs and evidence-based guidelines in CSDH, particularly including low- and middle-income countries, and it is hoped that the establishment of the iCORIC (International COllaborative Research Initiative on Chronic Subdural Haematoma) will help address this.
Entities:
Keywords:
Chronic subdural haematoma; Collaboration; Elderly; Head injury; Trials
Authors: David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman Journal: BMJ Date: 2010-03-23
Authors: Sae Min Kwon; Min Ho Lee; Youngbeom Seo; Young Il Kim; Hyuk-Jin Oh; Kyung Hwan Kim; Kyu-Sun Choi; Kyuha Chong Journal: Korean J Neurotrauma Date: 2022-04-25
Authors: Ellie Edlmann; Susan Giorgi-Coll; Eric P Thelin; Peter J Hutchinson; Keri L H Carpenter Journal: Front Neurol Date: 2022-09-08 Impact factor: 4.086
Authors: Dana C Holl; Ana Mikolic; Jurre Blaauw; Roger Lodewijkx; Merijn Foppen; Korné Jellema; Niels A van der Gaag; Heleen M den Hertog; Bram Jacobs; Joukje van der Naalt; Dagmar Verbaan; K H Kho; C M F Dirven; Ruben Dammers; Hester F Lingsma; David van Klaveren Journal: Acta Neurochir (Wien) Date: 2022-05-03 Impact factor: 2.816
Authors: Hyuk-Jin Oh; Youngbeom Seo; Yoon-Hee Choo; Young Il Kim; Kyung Hwan Kim; Sae Min Kwon; Min Ho Lee; Kyuha Chong Journal: J Korean Neurosurg Soc Date: 2021-11-04
Authors: Dana C Holl; Jurre Blaauw; Erwin Ista; Clemens M F Dirven; Kuan H Kho; Korné Jellema; Niels A van der Gaag; Ishita P Miah; Heleen M den Hertog; Joukje van der Naalt; Bram Jacobs; Dagmar Verbaan; Suzanne Polinder; Hester F Lingsma; Ruben Dammers Journal: Brain Behav Date: 2022-02-03 Impact factor: 2.708